Interim / Quarterly Report • Sep 29, 2025
Preview not available for this file type.
Download Source Fileauthor: "Zayyan Shabir"
date: 2025-09-26 11:27:00+00:00
processor: python-docx+mammoth
status: success
29 September 2025
ACCELER8 VENTURES PLC
Interim Report for the six months ended 30 June 2025
Acceler8 Ventures Plc (LSE: AC8, "AC8" or the "Company") announces its unaudited condensed interim results for the six month period to 30 June 2025.
Strategy
AC8 was established in 2021 to undertake one or more investment and / or acquisition opportunities of businesses operating within the UK or internationally across certain sectors.
The Company retains a flexible investment and acquisition strategy which will, subject to appropriate levels of due diligence, enable it to deploy capital in target companies by way of minority or majority investments, or full acquisitions where it is in the interests of shareholders to do so.
The Company’s strategic aim is to drive shareholder value through the acquisition of target companies in certain sectors where the Board believes there to be sustainable growth opportunities both organically, and through acquisition. Sectors of particular focus include gaming, media and entertainment, software and technology, industrials and business services.
The Company is the parent company of Acceler8 Ventures Subco Limited (a private limited company under the laws of Jersey with registered number 134587) and together will be referred to as the "Group" in these accounts.
Results and developments in the six month period to 30 June 2025
The Group’s loss after taxation was £70,997 (six month period to 30 June 2024: £83,033). This principally reflected operating expenses incurred as a listed business and due diligence activities of £71,001 (six month period to 30 June 2024: £83,477).
The Group generated a loss per share of £0.09 (six month period to 30 June 2024: £0.11).
As a result of tight cost control and moderate operating expenses, as at 30 June 2025, AC8’s cash balance was £1,399 (31 December 2024: £113).
On 18 June 2025, the Company held its Annual General Meeting in which all resolutions were unanimously passed.
Risks
As the Company has yet to complete an investment or acquisition, it has limited financial statements and / or historical financial data, and limited trading history. As such, the Group and Company during the period were subject to the risks and uncertainties associated with an early-stage acquisition company.
The Directors are of the opinion that these risks, which were detailed further in AC8’s published final results for the financial year ended 31 December 2024, remain applicable to the Group and Company.
Dividend
At this point in the Company's development, it does not anticipate declaring any dividends in the foreseeable future. Following the Company’s inaugural investment or acquisition, the Directors will determine an appropriate dividend policy for AC8.
Outlook
During the period, and post period end, AC8 has continued to pursue its investment and acquisition strategy and is currently assessing opportunities within its chosen sectors of interest.
It was disappointing that we were unable to conclude a transaction during the period, however we are seeing an increased flow of opportunities, which include successful businesses with the potential for high growth, that are seeking to partner with, and leverage the benefits of, the Board’s experience and that of the wider AC8 team.
Post the period end, we successfully completed a convertible loan note issuance raising £0.4 million to support the pursuit of our inaugural transaction and we are grateful for the support we received, and welcome our new investors to the Company.
As at 18 September 2025, the Company’s current unaudited cash balance was £0.3 million.
Statement of Directors’ responsibilities
The Directors confirm that these condensed interim financial statements have been prepared in accordance with UK adopted International Accounting Standard 34, 'Interim Financial Reporting' and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom’s Financial Conduct Authority and that the interim management report includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely:
| an indication of important events that have occurred during the first six months and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and | |
| material related-party transactions in the first six months and any material changes in the related-party transactions described in the last annual report. |
By order of the Board
David Williams
Chairman
28 September 2025
Enquiries:
| Tessera Investment Management Limited | |
| Tony Morris | +44 (0) 7742 189145 |
INTERIM CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
For the six months ended 30 June 2025
| Note | Six months ended 30 June 2025 Unaudited £ | Six months ended 30 June 2024 Unaudited £ | ||||
| Administrative expenses | (71,001) | (83,477) | ||||
| Operating loss | (71,001) | (83,477) | ||||
| Interest receivable | 5 | 4 | 444 | |||
| Loss on ordinary activities before taxation | (70,997) | (83,033) | ||||
| Taxation charge | - | - | ||||
| Loss and total comprehensive loss for the period | (70,997) | (83,033) | ||||
| Loss per share | ||||||
| Basic & diluted | 10 | (£0.09) | (£0.11) | |||
| Loss attributable to: | ||||||
| Owners of the parent company | (70,997) | (83,033) | ||||
The Group has no items of other comprehensive income in either the current or prior period. All activities in both the current and the prior period relate to continuing operations.
The accompanying notes form part of these interim condensed consolidated financial statements.
INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION
As at 30 June 2025
| Note | As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | ||
| Current assets | ||||
| Cash and cash equivalents | 7 | 1,399 | 113 | |
| Trade and other receivables | 8 | 5,929 | 7,472 | |
| Total current assets | 7,328 | 7,585 | ||
| Total assets | 7,328 | 7,585 | ||
| Current liabilities | ||||
| Trade and other payables | 9 | 124,533 | 53,949 | |
| Total current liabilities | 124,533 | 53,949 | ||
| Total liabilities | 124,533 | 53,949 | ||
| Total net liabilities | 117,205 | 46,364 | ||
| Equity | ||||
| Share capital | 12 | 7,500 | 7,500 | |
| Share premium | 13 | 729,598 | 729,598 | |
| Capital redemption reserve | 13 | 2 | 2 | |
| Share-based payment reserve | 13 | 1,242 | 1,086 | |
| Non-controlling interest | 13 | 67 | 67 | |
| Retained deficit | 13 | (855,614) | (784,617) | |
| Total equity attributable to equity holders of the Company | (117,205) | (46,364) |
The accompanying notes form part of these interim condensed consolidated financial statements.
INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For the six months ended 30 June 2024 (Unaudited)
| Share capital £ | Share premium £ | Capital redemption reserve £ | Share-based payment reserve £ | Non-controlling interest £ | Retained deficit £ | Total Equity £ | |||||||
| Balance as at 31 December 2023 | 7,500 | 729,598 | 2 | 772 | 67 | (624,137) | 113,802 | ||||||
| Loss for the period | - | - | - | - | - | (83,033) | (83,033) | ||||||
| Share-based payment charge | - | - | - | 157 | - | - | 157 | ||||||
| Balance as at 30 June 2024 | 7,500 | 729,598 | 2 | 929 | 67 | (707,170) | 30,926 |
For the six months ended 30 June 2025 (Unaudited)
| Share capital £ | Share premium £ | Capital redemption reserve £ | Share-based payment reserve £ | Non-controlling interest £ | Retained deficit £ | Total Equity £ | |||||||
| Balance as at 31 December 2024 | 7,500 | 729,598 | 2 | 1,086 | 67 | (784,617) | (46,364) | ||||||
| Loss for the period | - | - | - | - | - | (70,997) | (70,997) | ||||||
| Share-based payment charge | - | - | - | 156 | - | - | 156 | ||||||
| Balance as at 30 June 2025 | 7,500 | 729,598 | 2 | 1,242 | 67 | (855,614) | (117,205) |
The accompanying notes form part of these interim condensed consolidated financial statements.
INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS
For the six months ended 30 June 2025
| Six months ended 30 June 2025 Unaudited £ | Six months ended 30 June 2024 Unaudited £ | ||
| Cash flows from operating activities | |||
| Loss before income tax | (70,997) | (83,033) | |
| Adjustments for: | |||
| Share-based payment charge | 156 | 157 | |
| Interest receivable | (4) | (444) | |
| Operating cash flows before changes in working capital | (70,845) | (83,320) | |
| Increase in trade and other receivables | (1,543) | (2,170) | |
| Increase / (decrease) in trade and other payables | 70,584 | (22,596) | |
| Net cash used in operating activities | (1,282) | (108,086) | |
| Interest received | 4 | 446 | |
| Net cash inflow from financing activities | 4 | 446 | |
| Net increase / (decrease) in cash and cash equivalents | 1,286 | (107,640) | |
| Cash and cash equivalents at beginning of period | 113 | 160,441 | |
| Cash and cash equivalents at end of period | 1,399 | 52,801 |
The accompanying notes form part of these interim condensed consolidated financial statement
NOTES TO THE GROUP FINANCIAL INFORMATION
For the six months ended 30 June 2025
The Company is a public limited company incorporated and domiciled in Jersey, whose shares are publicly traded on the Main Market of the London Stock Exchange. The Company is the parent company of Acceler8 Ventures Subco Limited (a private limited company under the laws of Jersey with registered number 134587).
The address of its registered office 28 Esplanade, St. Helier, Channel Islands, JE2 3QA, Jersey.
The Company has been incorporated for the purpose of identifying suitable acquisition opportunities in accordance with the Group's investment and acquisition strategy with a view to creating shareholder value. The Group will retain a flexible investment and acquisition strategy which will, subject to appropriate levels of due diligence, enable it to deploy capital in target companies by way of minority or majority investments, or full acquisitions where it is in the interests of shareholders to do so. This will include transactions with target companies located in the UK and internationally.
These interim condensed consolidated financial statements and accompanying notes have neither been audited nor reviewed by the Company’s auditor.
The unaudited interim financial statements in this report have been prepared using accounting policies consistent with International Financial Reporting Standards (“IFRS”) as adopted by the UK. The accounting policies adopted in the interim financial statements are consistent with those adopted in the Group's last annual report for the year ended 31 December 2024 with regards to the measurement and recognition of each type of asset, liability, income and expense presented. The Group has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.
The interim condensed consolidated financial statements have been prepared on a going concern basis.
The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the Group’s annual report as at 31 December 2024, which is available on the Company’s website.
These interim financial statements present selected explanatory notes to explain events and transactions that are significant to an understanding of the changes in the Group’s financial position and performance since 31 December 2024.
The interim condensed consolidated financial statements are presented in £ and rounded to the nearest £ unless otherwise stated.
These interim condensed consolidated financial statements were approved by the Board of Directors on 28 September 2025.
Comparative figures
Comparative figures which have been presented cover the six- month period ended 30 June 2024. The statement of financial position comparative figures are shown as at 31 December 2024.
Statutory accounts
Financial information contained in this document does not constitute statutory accounts within the meaning of the Companies (Jersey) Law 1991. The statutory accounts for the year ended 31 December 2024 have been filed with the Registrar of Companies. The report of the auditors on those statutory accounts was unqualified and did not draw attention to any matters by way of emphasis.
The interim condensed consolidated financial statements are based on the following policies which have been consistently applied:
Basis of consolidation
The interim condensed consolidated financial statements present the results of the Company and its subsidiaries (the “Group”) as if they formed a single entity. Intercompany transactions and balances between Group companies are therefore eliminated in full.
Where the Group has control over a Company, it is classified as a subsidiary. The Group controls a company if all three of the following elements are present: power over the Company, exposure to variable returns from the Company, and the ability of the Group to use its power to affect those variable returns. Control is reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of control.
The interim condensed consolidated financial statements incorporate the results of business combinations using the acquisition method. In the interim consolidated statement of financial position, the acquiree’s identifiable assets, liabilities and contingent liabilities are initially recognised at their fair values at the acquisition date. The acquisition related costs are included in the consolidated statement of comprehensive income on an accruals basis. The results of acquired operations are included in the consolidated statement of comprehensive income from the date on which control is obtained.
Functional and presentational currency
The Group’s functional and presentational currency for these financial statements is the pound sterling.
Interest receivable
Interest receivable is recognised on a time-proportion basis using the effective interest rate method.
Employee benefits
Short-term employee benefit obligations are measured on an undiscounted basis and are expensed as the related service is provided. A liability is recognised for the amount expected to be paid under short-term cash bonus or profit-sharing plans if the Group has a present legal or constructive obligation to pay this amount as a result of past service provided by the employee and the obligation can be estimated reliably.
Cash and cash equivalents
Cash and cash equivalents comprise cash balances and short-term deposits with an original maturity of three months or less from inception, held for meeting short term commitments.
Equity
Equity comprises of share capital, share premium, capital redemption reserve, share based payment reserve, non-controlling interest and retained deficit.
Share capital is measured at the par value.
Share premium and retained deficit represent balances conventionally attributed to those descriptions. The transaction costs relating to the issue of shares was deducted from share premium.
The Capital redemption reserve is made up on amounts arising from the cancellation of the deferred shares.
Share-based payment reserve includes the cumulative share-based payment charged to equity.
Non-controlling interest reserve arises out of amounts due to holders of the B shares in Acceler8 Ventures Subco Limited.
Taxation
Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognised in the income statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity, in which case it is recognised in other comprehensive income or equity respectively.
Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates and laws enacted or substantively enacted at the statement of financial position date.
Deferred tax is provided on temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences are not provided for: the initial recognition of goodwill; the initial recognition of assets or liabilities that affect neither accounting nor taxable profit other than in a business combination, and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realisation or settlement of the carrying amount of assets and liabilities, using tax rates and laws enacted or substantively enacted at the statement of financial position date.
A deferred tax asset is recognised only to the extent that it is probable that future taxable profits will be available against which the temporary difference can be utilised.
Financial assets and liabilities
The Group’s financial assets and liabilities comprise of cash and cash equivalents, other receivables, and trade and other payables. Financial assets are stated at amortised cost less provision for expected credit losses. Financial liabilities are stated at amortised cost.
Share-based payments
The Group operates an equity-settled share-based payment plan. The fair value of the employee services received in exchange for the grant of options is recognised as an expense over the vesting period, based on the Group’s estimate of awards that will eventually vest, with a corresponding increase in equity as a share-based payment reserve.
This plan includes market-based vesting conditions for which the fair value at grant date reflects and are therefore not subsequently revisited. The fair value is determined using a binomial model.
Related party transactions
The Group discloses transactions with related parties which are not wholly owned with the same group. It does not disclose transactions with members of the same group that are wholly owned.
Standards in issue but not yet effective
At the date of authorisation of these financial statements there were amendments to standards which were in issue, but which were not yet effective, and which have not been applied. The principal ones were:
| Amendment to IFRS 9 and IFRS 7 - Classification and Measurement of Financial Instruments (effective for annual periods beginning on or after 1 January 2026) | |
| IFRS 18 Presentation and Disclosure in Financial Statements (effective for annual periods beginning on or after 1 January 2027) | |
| IFRS 19 Subsidiaries without Public Accountability: Disclosures (effective for annual periods beginning on or after 1 January 2027) |
The Directors do not expect the adoption of these amendments to standards to have a material impact on the financial statements.
In preparing the interim condensed consolidated financial statements, the Directors have to make judgments on how to apply the Group's accounting policies and make estimates about the future. The Directors do not consider there to be any critical judgments that have been made in arriving at the amounts recognised in the interim condensed consolidated financial statements.
| Six months ended 30 June 2025 Unaudited £ | Six months ended 30 June 2024 Unaudited £ | ||
| Bank interest receivable | 4 | 444 |
Principal subsidiary undertakings of the Group
The Company directly owns the ordinary share capital of its subsidiary undertakings as set out below:
| Subsidiary | Nature of business | Country of incorporation | Proportion of A ordinary shares held by Company | Proportion of B ordinary shares held by Company |
| Acceler8 Ventures Subco Limited | Intermediate holding company | Jersey, Channel Islands | 100 per cent. | 0 per cent. |
The address of the registered office of Acceler8 Ventures Subco Limited (the "Subco") is 28 Esplanade, St. Helier, Channel Islands, JE2 3QA, Jersey. The Subco was incorporated on 25 March 2021 and prepares its own financial statements for the period ended 31 March each year.
The A ordinary shares have full voting rights, full rights to participate in a dividend and full rights to participate in a distribution of capital. The B ordinary shares have been issued pursuant to the Company’s Subco Incentive Scheme and hold no voting or dividend rights or rights to distribution.
| As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | ||
| Cash at bank and in hand | 1,399 | 113 |
| As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | ||
| Other receivables | 3 | 3 | |
| Prepayments | 5,926 | 7,469 | |
| Total | 5,959 | 7,472 |
| As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | ||
| Trade creditors | 57,310 | - | |
| Accruals | 51,797 | 53,949 | |
| Director loans | 15,426 | - | |
| Total | 124,533 | 53,949 |
| Six months ended 30 June 2025 Unaudited £ | Six months ended 30 June 2024 Unaudited £ | ||
| Loss attributable to the equity holders of the Company | (70,557) | (83,033) | |
| Weighted number of shares in issue | 750,000 | 750,000 | |
| Loss per share (£) | (0.09) | (0.11) |
| As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | ||
| Financial assets | |||
| Cash and cash equivalents | 1,399 | 113 | |
| Other receivables | 3 | 3 | |
| 1,402 | 116 |
| As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | ||
| Financial liabilities | |||
| Trade creditors | 57,310 | - | |
| Accruals | 51,797 | 53,949 | |
| Director loans | 15,426 | - | |
| 124,533 | 53,949 |
Financial risk management objectives and policies
The Group’s financial assets and liabilities comprise of cash and cash equivalents, other receivables and accruals. The carrying value of all financial assets and liabilities equals fair value given their short-term nature.
Credit risk
The Group's credit risk is wholly attributable to its cash balance. All cash balances are held at a reputable bank in Jersey. The credit risk from its cash and cash equivalents is deemed to be low due to the nature and size of the balances held.
Liquidity risk
Liquidity risk is the risk that the Group will not be able to meet its financial obligations as they fall due.
The Group’s approach to liquidity risk is to ensure that sufficient liquidity is available to meet foreseeable requirements and to invest funds securely and profitably.
| Allocated, called up and fully paid | |||||||
| As at 30 June 2025 Unaudited Number | As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited Number | As at 31 December 2024 Audited £ | ||||
| Ordinary shares of 1p each | 750,000 | 7,500 | 750,000 | 7,500 |
Share premium and retained deficit represent balances conventionally attributed to those descriptions. The transaction costs relating to the issue of shares was deducted from share premium.
The Capital redemption reserve is made up on amounts arising from the cancellation of the deferred shares.
Share-based payment reserve includes the cumulative share-based payment charged to equity.
Non-controlling interest reserve arises out of amounts due to holders of the B shares in Acceler8 Ventures Subco Limited.
The Group having no regulatory capital or similar requirements, its primary capital management focus is on maximising earnings per share and therefore shareholder return.
On 14 July 2021, the Group created a Subco Incentive Scheme within its wholly owned subsidiary Acceler8 Ventures Subco Limited ("Subco"). Under the terms of the Subco Incentive Scheme, scheme participants are only rewarded if a predetermined level of shareholder value is created over a three to five year period or upon a change of control of the Company or Subco (whichever occurs first), calculated on a formula basis by reference to the growth in market capitalisation of the Company, following adjustments for the issue of any new Ordinary shares and taking into account dividends and capital returns ("Shareholder Value"), realised by the exercise by the beneficiaries of a put option in respect of their shares in Subco and satisfied either in cash or by the issue of new ordinary shares at the election of the Company.
Under these arrangements in place, participants are entitled to up to 15 per cent. of the Shareholder Value created, subject to such Shareholder Value having increased by at least 12.5 per cent. per annum compounded over a period of between three and five years from admission or following a change of control of the Company or Subco.
The Subco Incentive Scheme detailed in Note 14 is an equity-settled share option plan which allows employees and advisors of the Group to sell their B shares to the company in exchange for a cash payment or for shares in the Company (at the Company’s election) if certain conditions are met.
These conditions include good and bad leaver provisions and that growth in Shareholder Value of 12.5 per cent. compound per annual is delivered over a three to five year period for the scheme to vest. This second condition is therefore a market condition which has been taken into account in the measurement at grant date of the fair value of the options.
The weighted average exercise price of the outstanding B share options is £1.00 which have a weighted average contractual life of 2 years 3 months. No B share options were issued in the period, all of which were outstanding at the period end. No B share options were exercised in the period. No B share options have expired during the period.
The Group recognised £156 (six months ended 30 June 2024: £157) of expenditure in the statement of total comprehensive income in relation to equity-settled share-based payments in the period.
The fair value of options granted during the period is determined by applying a binominal model. The expense is apportioned over the vesting period of the option and is based on the number which are expected to vest and the fair value of these options at the date of grant.
The inputs into the binomial model in respect of options granted in the period are as follows:
| Opening share price | £1 | |||
| Expected volatility of share price | 16.67% | |||
| Expected life of options | 5 years | |||
| Risk-free rate | 0.71% | |||
| Target increase in share price per annum | 12.5% | |||
| Fair value of options | 5.397p |
Expected volatility was estimated by reference to the average 5-year volatility of the FTSE SmallCap Index.
The target increase in Shareholder Value is laid out in the Articles of Association of the Subco and represents the compounded target annual increase in market capitalisation (adjusted for capital raises and dividends) that needs to be met between the third and fifth anniversary of the Group’s admission onto the Main Market of the London Stock Exchange in order for the scheme to vest.
The Group did not enter into any share-based payment transactions with parties other than employees and advisors during the current period.
Transactions with key management personnel
Key management personnel comprise the directors. The total emoluments for key management personnel in the period was £20,000 (six months ended 30 June 2024: £20,000). During the period, £20,000 of director fees were accrued (six months ended 30 June 2024: nil).
Other transactions
During the six months ended 30 June 2025, the directors provided unsecured loans to the Group of £15,426 (six months ended 30 June 2024: £nil). No interest is payable by the Group. As at 30 June 2025, the balance outstanding was £15,426 (as at 30 June 2025: £nil) and is included in trade and other payables.
There are no contingent liabilities at the reporting date which would have a material impact on the financial statements.
On 3 July 2025, trading in the Company’s ordinary shares was restored following the cessation of the proposed acquisition of Verifyyed, Inc., which was announced on 17 June 2025.
On 29 August 2025, the Group also announced that it had successfully raised £380,000 through the issue of unsecured Convertible Loan Notes (“CLNs”). The CLN’s were issued to new investors to raise funds to support the Company’s modest working capital requirements in pursuit of an initial transaction. The principal terms of the CLNs are as follows:
Amount: £380,000
Interest rate: 8 per cent. per annum, payable-in-kind and compounding annual
Redemption: no redemption rights applicable save for agreement by the Noteholder following a tender offer by the Company
Conversion: Automatic conversion of principal and accrued interest on the earlier of completion of an Initial Transaction (as defined by UKLR 13.4.1) and the third anniversary of CLN issuance
Conversion price: The lower of £1 per Ordinary Share and a 30 percent. discount to the prevailing price per Ordinary Share applicable to the Initial Transaction, or a 30 per cent. discount to a 20-trading day VWAP as at close on the last trading day prior to the third anniversary of CLN issuance
Security: The CLNs rank pari passu with other unsecured creditors of the Company
In the opinion of the Directors, there is no single ultimate controlling party.
Have a question? We'll get back to you promptly.